Najnovejša delovna mesta v podjetju Stoke Therapeutics

Stoke Therapeutics
Stoke Therapeutics
1 Indeksirana delovna mesta
Ustanovljeno 2017
201 – 500 Zaposleni
BiotehnologijaFarmacevtski izdelkiZdravstveno varstvo
Stoke Therapeutics is a biotechnology company developing RNA-based medicines for rare genetic diseases. Its TANGO platform uses antisense oligonucleotides to increase gene expression, aiming to help patients produce more protein from their own genes in conditions where one working copy of a gene is insufficient. The company’s lead program, STK‑001, is in development for Dravet syndrome, a genetic epilepsy associated with SCN1A haploinsufficiency. Other programs focus on genetic neurology and rare disease indications.

Filtri